Dubai – It has taken more than a decade for a 59-year-old Sudanese woman with achalasia, a rare oesophageal disorder, to ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

“Weight loss that is not sustainable compromises your body’s capacity to function optimally. Instead of improving on health, it puts you at a risk of developing health issues. So do the right thing by ...